Tsai KC - Search Results

1

Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo.

Yu KH, Kuo CY, Wu IT, Chi CH, Tsai KC, Kuo PC, Zeng JW, Hung CC, Hung HY. Yu KH, et al. Among authors: tsai kc. Eur J Pharmacol. 2023 Dec 5;960:176146. doi: 10.1016/j.ejphar.2023.176146. Epub 2023 Oct 24. Eur J Pharmacol. 2023. PMID: 37884184

2

Design and synthesis of pyrazole derivatives against neutrophilic inflammation.

Yu KH, Tien KW, Wang WC, Chi CH, Tsai KC, Chou CH, Hwang TL, Hung HY. Yu KH, et al. Among authors: tsai kc. Eur J Med Chem. 2023 Dec 15;262:115874. doi: 10.1016/j.ejmech.2023.115874. Epub 2023 Oct 26. Eur J Med Chem. 2023. PMID: 37918036

3

Discovery of oral chemotherapeutic reversal agents for treating multidrug resistance cancer.

Yu KH, Wu IT, Yu CP, Wang WC, Chi CH, Tsai KC, Chou CH, Hung CC, Hung HY. Yu KH, et al. Among authors: tsai kc. Eur J Pharmacol. 2024 Aug 15;977:176682. doi: 10.1016/j.ejphar.2024.176682. Epub 2024 May 31. Eur J Pharmacol. 2024. PMID: 38823759

4

The first attempt in synthesis, identification, and evaluation of SEPT9 inhibitors on human oral squamous carcinomas.

Lai HY, Yu KH, Tsai KC, Lee CC, Wang HY, Hsieh YP, Chiang KY, Kuo PL, Huang TT, Hung HY. Lai HY, et al. Among authors: tsai kc. Bioorg Chem. 2024 Dec 16;154:108068. doi: 10.1016/j.bioorg.2024.108068. Online ahead of print. Bioorg Chem. 2024. PMID: 39705938

5

Discovery and biological evaluation of potent 2-trifluoromethyl acrylamide warhead-containing inhibitors of protein disulfide isomerase.

Chu JC, Tsai KC, Wang TY, Chen TY, Tsai JY, Lee T, Lin MH, Hsieh YSY, Wu CC, Huang WJ. Chu JC, et al. Among authors: tsai kc. Eur J Med Chem. 2024 Dec 16;283:117169. doi: 10.1016/j.ejmech.2024.117169. Online ahead of print. Eur J Med Chem. 2024. PMID: 39708767

6

Peramivir conjugates as orally available agents against influenza H275Y mutant.

Wang PC, Chiu DC, Jan JT, Huang WI, Tseng YC, Li TT, Cheng TJ, Tsai KC, Fang JM. Wang PC, et al. Among authors: tsai kc. Eur J Med Chem. 2018 Feb 10;145:224-234. doi: 10.1016/j.ejmech.2017.12.072. Epub 2017 Dec 24. Eur J Med Chem. 2018. PMID: 29324342

7

Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses.

Hsu PH, Chiu DC, Wu KL, Lee PS, Jan JT, Cheng YE, Tsai KC, Cheng TJ, Fang JM. Hsu PH, et al. Among authors: tsai kc. Eur J Med Chem. 2018 Jun 25;154:314-323. doi: 10.1016/j.ejmech.2018.05.030. Epub 2018 May 21. Eur J Med Chem. 2018. PMID: 29843102

8

Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer.

Chiang CW, Lin YS, Chang FL, Lin TY, Tsai KC, HuangFu WC, Lee YC. Chiang CW, et al. Among authors: tsai kc. Biochem Biophys Res Commun. 2023 Nov 5;680:161-170. doi: 10.1016/j.bbrc.2023.09.025. Epub 2023 Sep 15. Biochem Biophys Res Commun. 2023. PMID: 37741263

9

Tamiphosphor monoesters as effective anti-influenza agents.

Chen CL, Lin TC, Wang SY, Shie JJ, Tsai KC, Cheng YS, Jan JT, Lin CJ, Fang JM, Wong CH. Chen CL, et al. Among authors: tsai kc. Eur J Med Chem. 2014 Jun 23;81:106-18. doi: 10.1016/j.ejmech.2014.04.082. Epub 2014 May 2. Eur J Med Chem. 2014. PMID: 24836064

10

NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model.

Wei WC, Tsai KC, Liaw CC, Chiou CT, Tseng YH, Liao GY, Lin YC, Chiou WF, Liou KT, Yu IS, Shen YC, Su YC. Wei WC, et al. Among authors: tsai kc. Front Pharmacol. 2023 Jun 21;14:1125414. doi: 10.3389/fphar.2023.1125414. eCollection 2023. Front Pharmacol. 2023. PMID: 37416063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters